Loading…

Beneficial Effects of a Novel Inhibitor of Platelet-Derived Growth Factor Receptor Autophosphorylation in the Rat with Mesangial Proliferative Glomerulonephritis

1. Our original compound, Ki6896 ((4- t-butylphenyl){4-[(6,7-dimethoxy-4-quinolyl) oxy]phenyl} methanone) strongly inhibited the autophosphorylation of platelet-derived growth factor (PDGF) β-receptor (IC 50=0.31 μM) and that of basic fibroblast growth factor receptor (IC 50=3.1 μM), whereas it did...

Full description

Saved in:
Bibliographic Details
Published in:General pharmacology 1998-11, Vol.31 (5), p.765-773
Main Authors: Yagi, Mikio, Kato, Shinichiro, Kobayashi, Yoshiko, Kobayashi, Nami, Iinuma, Noriko, Nakamura, Kazuhide, Kubo, Kazuo, Ohyama, Shin-Ichi, Murooka, Hideko, Shimizu, Toshiyuki, Nishitoba, Tsuyoshi, Osawa, Tatsushi, Nagano, Nobuo
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:1. Our original compound, Ki6896 ((4- t-butylphenyl){4-[(6,7-dimethoxy-4-quinolyl) oxy]phenyl} methanone) strongly inhibited the autophosphorylation of platelet-derived growth factor (PDGF) β-receptor (IC 50=0.31 μM) and that of basic fibroblast growth factor receptor (IC 50=3.1 μM), whereas it did not inhibit some other kinases. 2. The [ 3H]thymidine incorporation and the growth of mesangial cells under the stimulation of PDGF were inhibited by Ki6896 in a dose-dependent manner. 3. In the mesangial proliferative glomerulonephritis rats induced by anti-Thy-1 monoclonal antibody, glomerulosclerosis was ameliorated and the number of glomerular proliferating cells was decreased by the daily administration of Ki6896. However, the accumulation of type I collagen and fibronectin in the glomeruli was not suppressed by Ki6896.
ISSN:0306-3623
1879-0011
DOI:10.1016/S0306-3623(98)00104-9